CellCarta
Martin LeBlanc is an accomplished executive and board member with extensive experience in the biotechnology and life sciences sectors. Currently serving as a Board Member at Sygnature Discovery and iXCells Biotechnologies, LeBlanc is also the Co-founder and Vice-Chairman of CellCarta, as well as President & Chief Executive Officer. Additional leadership roles include Chairman of the Board at Icentia Inc. and participation on the boards of Mispro Biotech Services Corporation, NuChem Sciences, and other organizations. LeBlanc co-founded Caprion Biosciences Inc. and held the position of President & CEO there until 2019, and has been involved with various companies as a board member throughout a distinguished career. Educational credentials include a Master's degree in Philosophy, Politics and Economics from the University of Oxford and a Bachelor's degree in Economics from Université de Moncton.
This person is not in the org chart
This person is not in any teams
CellCarta
CellCarta's Mission is centered on collaborating and partnering with pharmaceutical and biotech companies through proteomics and immune monitoring enabling the acceleration of precision medicine in drug development.With a vision and deep understanding of the needs for complex immune monitoring in novel drug development, Caprion integratedImmuneCarta (formerly known as National Immune Monitoring), with its established and proven proteomics service, ProteoCarta. Together, Caprion now offers a fully integrated and unique service offering to its partners.